Metastatic Dedifferentiated Liposarcoma: 16 Clinical Trials, Page 1 of 2

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Condition(s):Advanced Dedifferentiated Liposarcoma; Locally Advanced Dedifferentiated Liposarcoma; Metastatic Dedifferentiated Liposarcoma; Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8; Unresectable Dedifferentiated LiposarcomaLast Updated:January 23, 2023Not yet recruiting

Efficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter Trial

Condition(s):Adult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated LiposarcomaLast Updated:January 25, 2021Terminated

Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma

Condition(s):Metastatic Angiosarcoma; Metastatic Dedifferentiated Liposarcoma; Metastatic Osteosarcoma; Recurrent Angiosarcoma; Recurrent Dedifferentiated Liposarcoma; Recurrent Osteosarcoma; Refractory Dedifferentiated Liposarcoma; Refractory OsteosarcomaLast Updated:November 2, 2022Recruiting

Ph II Cabazitaxel DD Liposarcoma

Condition(s):Dedifferentiated LiposarcomaLast Updated:September 14, 2021Completed

The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma

Condition(s):Sarcoma, Soft TissueLast Updated:July 14, 2020Recruiting

Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial

Condition(s):Advanced and / or Metastatic LiposarcomaLast Updated:July 23, 2020Completed

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Condition(s):Sarcoma; Advanced Sarcoma; High Grade Sarcoma; Leiomyosarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Dedifferentiated LiposarcomaLast Updated:October 27, 2022Active, not recruiting

Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma

Condition(s):Dedifferentiated LiposarcomaLast Updated:August 5, 2022Active, not recruiting

Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)

Condition(s):Soft Tissue SarcomaLast Updated:January 4, 2023Active, not recruiting

Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Condition(s):Locally Advanced Bone Sarcoma; Locally Advanced Dedifferentiated Liposarcoma; Locally Advanced Gastrointestinal Stromal Tumor; Locally Advanced Soft Tissue Sarcoma; Metastatic Bone Sarcoma; Metastatic Liposarcoma; Metastatic Soft Tissue Sarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma; Metastatic Unresectable Sarcoma; Pleomorphic Liposarcoma; Stage III Bone Sarcoma AJCC v7; Stage III Soft Tissue Sarcoma AJCC v7; Stage IV Bone Sarcoma AJCC v7; Stage IV Soft Tissue Sarcoma AJCC v7; Stage IVA Bone Sarcoma AJCC v7; Stage IVB Bone Sarcoma AJCC v7; Unresectable Bone Sarcoma; Unresectable Dedifferentiated Liposarcoma; Unresectable Liposarcoma; Unresectable Malignant Gastrointestinal Stromal Tumor; Unresectable Soft Tissue SarcomaLast Updated:October 19, 2022Active, not recruiting

1 2 »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.